Title of article
18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Other Thyroid Cancers: Medullary, Anaplastic, Lymphoma and So Forth
Author/Authors
Çayır, Derya Dışkapı Yıldırım Beyazıt Training and Research Hospital - Clinic of Nuclear Medicine - Ankara, Turkey , Araz, Mine Dışkapı Yıldırım Beyazıt Training and Research Hospital - Clinic of Nuclear Medicine - Ankara, Turkey
Pages
8
From page
1
To page
8
Abstract
Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) is used in staging, restaging, and evaluation of therapy response in many cancers as well as differentiated thyroid carcinomas especially in non-iodine avid variants. Its potential in less frequent thyroid tumors like medullary, anaplastic thyroid cancers, thyroid lymphoma and metastatic tumors of the thyroid however, is not well established yet. The aim of this review is to provide an overview on the recent applications and indications of 18F-FDG PET/CT in these tumors and to focus on the controversies in the clinical setting.
Keywords
18F-fluorodeoxyglucose , positron emission tomography , Thyroid cancer
Journal title
Molecular Imaging and Radionuclide Therapy
Serial Year
2017
Record number
2575707
Link To Document